论文信息 - Rapsody: randomized prospective phase II trial of two schedules of sorafenib daily and interferon-α 2A (IFN) in metastatic renal cell carcinoma (MRCC). GOIRC study 0681 - 字舞流文

Rapsody: randomized prospective phase II trial of two schedules of sorafenib daily and interferon-α 2A (IFN) in metastatic renal cell carcinoma (MRCC). GOIRC study 0681

C. Porta | C. Boni | A. Santoro | A. Falcone | S. Bracarda | C. Caserta | D. Gasparro | A. Contu | F. Artioli | F. D. Costanzo | V. Angelis | C. Bartolomeo | R. Bianca | L. Sordini